Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Welcome
Go
Free Newsletter Sign Up

Patent Office Extends Covid-19, Cancer Therapy Pilot Programs

June 28, 2022, 3:40 PM

The US Patent and Trademark Office is extending two pilot programs for prioritizing examination of patents related to Covid-19 and cancer therapies, the office announced Tuesday.

The programs have expedited consideration of hundreds of patents, with more than 260 Covid-19-related patents and more than 600 cancer patents issued under the programs, according to the PTO.

The PTO said in a Federal Register notice that it would continue to accept, through Dec. 31, requests to expedite consideration of patent applications regarding innovations to combat the coronavirus pandemic under its Modified Covid-19 Prioritized Examination Pilot Program.

It’s the latest in a series ...